1. Home
  2. SNY vs GSBC Comparison

SNY vs GSBC Comparison

Compare SNY & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • GSBC
  • Stock Information
  • Founded
  • SNY 1994
  • GSBC 1923
  • Country
  • SNY France
  • GSBC United States
  • Employees
  • SNY N/A
  • GSBC N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • GSBC Major Banks
  • Sector
  • SNY Health Care
  • GSBC Finance
  • Exchange
  • SNY Nasdaq
  • GSBC Nasdaq
  • Market Cap
  • SNY 116.5B
  • GSBC 665.7M
  • IPO Year
  • SNY N/A
  • GSBC N/A
  • Fundamental
  • Price
  • SNY $48.61
  • GSBC $60.75
  • Analyst Decision
  • SNY Buy
  • GSBC Hold
  • Analyst Count
  • SNY 2
  • GSBC 2
  • Target Price
  • SNY $62.50
  • GSBC $59.50
  • AVG Volume (30 Days)
  • SNY 2.2M
  • GSBC 91.9K
  • Earning Date
  • SNY 07-31-2025
  • GSBC 07-16-2025
  • Dividend Yield
  • SNY 3.29%
  • GSBC 2.60%
  • EPS Growth
  • SNY 39.56
  • GSBC 10.52
  • EPS
  • SNY 5.45
  • GSBC 5.60
  • Revenue
  • SNY $48,817,552,946.00
  • GSBC $219,572,000.00
  • Revenue This Year
  • SNY $3.39
  • GSBC N/A
  • Revenue Next Year
  • SNY $7.05
  • GSBC $1.04
  • P/E Ratio
  • SNY $8.92
  • GSBC $11.00
  • Revenue Growth
  • SNY N/A
  • GSBC N/A
  • 52 Week Low
  • SNY $45.80
  • GSBC $47.58
  • 52 Week High
  • SNY $60.12
  • GSBC $68.02
  • Technical
  • Relative Strength Index (RSI)
  • SNY 46.26
  • GSBC 59.19
  • Support Level
  • SNY $47.99
  • GSBC $61.18
  • Resistance Level
  • SNY $49.43
  • GSBC $62.90
  • Average True Range (ATR)
  • SNY 0.58
  • GSBC 1.36
  • MACD
  • SNY 0.18
  • GSBC 0.19
  • Stochastic Oscillator
  • SNY 56.15
  • GSBC 68.14

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.

Share on Social Networks: